Elevated troponin in patients with acute gastrointestinal bleeding: prevalence, predictors and outcomes

3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Cardiac troponin (cTn) can also be elevated in patients with non-cardiac illnesses. The utility of elevated cTn in patients with acute gastrointestinal bleeding (AGIB) is unclear. Methods: We retrospectively identified all patients admitted with AGIB who had cTn ordered. We assessed the prevalence, predictors and mortality. Results: A total of 172 patients with AGIB were included in the study, of whom 17% had abnormal cTn. Predictors of elevated cTn were advanced age, lower BMI, coronary artery disease and chronic kidney disease. The abnormal cTn group had more cardiac consultation and procedures and longer length of stay. However, there was no difference in mortality between the two groups. Conclusion: Elevated cTn in patients with AGIB was associated with more cardiology consultation and downstream cardiac testing, greater delay to endoscopic evaluation and longer length of stay, without significantly affecting the mortality.

Cite

CITATION STYLE

APA

Kousa, O., Addasi, Y., MacHanahalli Balakrishna, A., Pajjuru, V. S. K., Bardwell, J. K., Walters, R. W., … Alla, V. M. (2022). Elevated troponin in patients with acute gastrointestinal bleeding: prevalence, predictors and outcomes. Future Cardiology, 18(9), 709–717. https://doi.org/10.2217/fca-2021-0143

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free